Showing results (21-30 of 580) with videos related to
Sort By:
Pageof 58
Current Treatment Options in Oncology|July 1, 2020
Treatment of Relapsed Acute Myeloid LeukemiaFelicitas Thol, Arnold GanserGenes, Chromosomes & Cancer|June 6, 2014
TET2 mutations in cytogenetically normal acute myeloid leukemia: clinical implications and evolutionary patternsFrederik Damm, Birgit Markus, Felicitas Thol, et al.Plos One|August 31, 2017
miR-625-3p is upregulated in CD8+ T cells during early immune reconstitution after allogeneic stem cell transplantationKriti Verma, Nidhi Jyotsana, Ivonne Buenting, et al.Annals of Hematology|April 26, 2013
Monitoring dendritic cell and cytokine biomarkers during remission prior to relapse in patients with FLT3-ITD acute myeloid leukemiaMareike Rickmann, Laura Macke, Bala Sai Sundarasetty, et al.Haematologica|January 19, 2011
FLT3-internal tandem duplication and age are the major prognostic factors in patients with relapsed acute myeloid leukemia with normal karyotypeKatharina Wagner, Frederik Damm, Felicitas Thol, et al.Current Opinion in Oncology|October 9, 2008
Erythropoietin in cancer-related anemiaMartin H Fenner, Arnold GanserHematology (Amsterdam, Netherlands)|June 16, 2001
The AML1/MTG8 Fusion Transcript in t(8;21) Positive AML and its Implication for the Detection of Minimal Residual Disease; MalignancyJÜrgen Krauter, Gerhard Heil, Arnold GanserBlood|November 9, 2023
How I treat refractory and relapsed acute myeloid leukemiaFelicitas Thol, Hartmut Döhner, Arnold GanserAdvances in Experimental Medicine and Biology|February 11, 2003
Invasive drug deliveryUlrike Blömer, Arnold Ganser, Michaela ScherrBritish Journal of Haematology|May 6, 2024
The Menin story in acute myeloid leukaemia-The road to successMichael W M Kühn, Arnold GanserPageof 58